SELLAS Life Sciences Group, Inc. - Common Stock, par value $0.0001 per share (SLS) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2019 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
SLS on Nasdaq
Shares outstanding
152,677,102
Price per share
$3.89
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
35,354,015
Total reported value
$133,285,596
% of total 13F portfolios
0%
Share change
+2,424,827
Value change
+$23,383,483
Number of holders
109
Price from insider filings
$3.89
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of SELLAS Life Sciences Group, Inc. - Common Stock, par value $0.0001 per share (SLS) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Anson Funds Management LP 4.9% -13% $31,046,889 +$6,010,196 7,481,178 +24% Anson Funds Management LP 31 Dec 2025
VANGUARD GROUP INC 6.7% $14,661,610 6,694,799 The Vanguard Group 30 Jun 2025
HIGHBRIDGE CAPITAL MANAGEMENT LLC 3.7% $24,560,261 6,514,658 Highbridge Capital Management, LLC 31 Dec 2025
BlackRock, Inc. 5.4% $9,155,886 5,686,886 BlackRock, Inc. 30 Sep 2025

As of 31 Dec 2025, 109 institutional investors reported holding 35,354,015 shares of SELLAS Life Sciences Group, Inc. - Common Stock, par value $0.0001 per share (SLS). This represents 23% of the company’s total 152,677,102 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of SELLAS Life Sciences Group, Inc. - Common Stock, par value $0.0001 per share (SLS) together control 22% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 5.5% 8,467,400 +24% 0% $31,922,098
BlackRock, Inc. 4.9% 7,541,054 +33% 0% $28,429,774
GEODE CAPITAL MANAGEMENT, LLC 2% 3,077,337 +36% 0% $11,604,041
STATE STREET CORP 1.4% 2,188,171 +61% 0% $8,249,405
MILLENNIUM MANAGEMENT LLC 0.91% 1,387,849 +341% 0% $5,232,191
MARSHALL WACE, LLP 0.88% 1,340,668 -43% 0% $5,054,320
TWO SIGMA INVESTMENTS, LP 0.71% 1,082,207 +642% 0.01% $4,079,920
Nuveen, LLC 0.67% 1,023,961 +2.6% 0% $3,860,333
NORTHERN TRUST CORP 0.61% 930,750 +27% 0% $3,508,927
MORGAN STANLEY 0.58% 890,929 -16% 0% $3,358,802
DAGCO, INC. 0.38% 577,540 0.5% $2,177,326
BARCLAYS PLC 0.33% 511,034 +180% 0% $1,926,599
Clear Street Group Inc. 0.33% 500,000 0.01% $1,885,000
Everhart Financial Group, Inc. 0.31% 466,216 +41% 0.16% $1,757,634
JONES FINANCIAL COMPANIES LLLP 0.28% 429,243 +114671% 0% $1,618,246
GOLDMAN SACHS GROUP INC 0.27% 411,654 +2037% 0% $1,551,936
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.27% 408,401 +39% 0% $1,539,672
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.23% 349,755 -59% 0% $1,318,577
GSA CAPITAL PARTNERS LLP 0.23% 345,052 -34% 0.11% $1,301,000
Opus Capital Group, LLC 0.21% 317,100 +27% 0.13% $1,195,000
WELLS FARGO & COMPANY/MN 0.2% 299,305 +295% 0% $1,128,380
Bank of New York Mellon Corp 0.17% 256,409 +25% 0% $966,663
Mariner, LLC 0.1% 159,150 +46% 0% $599,996
RHUMBLINE ADVISERS 0.08% 129,309 -5.4% 0% $487,489
XTX Topco Ltd 0.08% 118,440 0.01% $446,519

Institutional Holders of SELLAS Life Sciences Group, Inc. - Common Stock, par value $0.0001 per share (SLS) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 35,354,015 $133,285,596 +$23,383,483 $3.77 109
2025 Q3 32,917,301 $53,012,951 +$9,796,863 $1.61 92
2025 Q2 26,771,579 $58,629,839 +$27,498,028 $2.19 78
2025 Q1 14,287,843 $15,431,614 +$8,743,246 $1.08 43
2024 Q4 6,195,241 $6,443,955 +$751,049 $1.04 29
2024 Q3 5,385,570 $6,729,539 +$1,661,405 $1.25 30
2024 Q2 4,056,846 $4,828,846 -$3,466,325 $1.19 29
2024 Q1 7,717,105 $7,794,727 +$4,207,509 $1.01 27
2023 Q4 3,493,044 $3,702,505 +$352,826 $1.06 29
2023 Q3 2,751,676 $4,512,830 -$594,241 $1.64 25
2023 Q2 3,114,137 $4,889,035 +$175,383 $1.57 22
2023 Q1 2,996,127 $4,284,993 +$1,438,716 $1.43 20
2022 Q4 1,889,269 $4,456,259 +$91,291 $2.36 27
2022 Q3 2,186,943 $4,418,000 -$1,738,313 $2.02 25
2022 Q2 2,979,307 $6,641,000 +$1,671,317 $2.23 23
2022 Q1 1,688,629 $11,276,000 -$279,247 $6.68 25
2021 Q4 1,733,782 $9,586,000 -$1,340,161 $5.53 26
2021 Q3 1,859,470 $17,100,000 -$844,204 $9.16 29
2021 Q2 1,897,926 $21,282,000 +$4,739,163 $11.10 28
2021 Q1 1,552,743 $13,246,990 +$5,287,808 $8.54 28
2020 Q4 925,075 $5,374,000 +$2,503,596 $5.81 17
2020 Q3 616,674 $1,633,000 +$397,179 $2.65 10
2020 Q2 455,904 $1,335,000 +$144,563 $2.93 12
2020 Q1 415,637 $720,000 -$87,849 $1.74 10
2019 Q4 389,002 $1,672,000 +$1,672,000 $4.30 9